Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors
2020-01-01 Pasculli, B; Barbano, R; Fontana, A; Biagini, T; Di Viesti, Mp; Rendina, M; Valori, Vm; Morritti, M; Bravaccini, S; Ravaioli, S; Maiello, E; Graziano, P; Murgo, R; Copetti, M; Mazza, T; Fazio, Vm; Esteller, M; Parrella, P
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
2020-01-01 Palleschi, M.; Maltoni, R.; Sarti, S.; Melegari, E.; Bravaccini, S.; Rocca, A.
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement
2020-01-01 Bronte, G; Delmonte, A; Burgio, Ma; Verlicchi, A; Puccetti, M; Bravaccini, S; Cravero, P; Tumedei, Mm; Diano, D; Rossi, G; Ulivi, P; Martinelli, G; Crino, L
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer A case report
2020-01-01 Maltoni, R; Palleschi, M; Gallerani, G; Bravaccini, S; Cecconetto, L; Melegari, E; Altini, M; Rocca, A
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance
2015-01-01 Genestreti, G; Bongiovanni, A; Burgio, Ma; Burgio, Sl; Musto, A; Rossi, A; Monti, M; Scarpi, E; Ulivi, P; Bravaccini, S; Dubini, A; Matteucci, F; Gavelli, G
International consensus on severe lung cancer-the first edition
2021-01-01 Zhou, C; Li, S; Liu, J; Chu, Q; Miao, L; Cai, L; Cai, X; Chen, Y; Cui, F; Dong, Y; Dong, W; Fang, W; He, Y; Li, W; Li, M; Liang, W; Lin, G; Lin, J; Lin, X; Liu, H; Liu, M; Mu, X; Hu, Y; Hu, J; Jin, Y; Li, Z; Qin, Y; Ren, S; Sun, G; Shen, Y; Su, C; Tang, K; Wu, L; Wang, M; Wang, H; Wang, K; Wang, Y; Wang, P; Wang, H; Wang, Q; Wang, Z; Xie, X; Xie, Z; X, Xu; Xu, F; Yang, M; Yang, B; Yi, X; Ye, X; Ye, F; Yu, Z; Yue, D; Zhang, B; Zhang, J; Zhang, J; Zhang, X; Zhang, W; Zhao, W; Zhu, B; Zhu, Z; Zhong, W; Bai, C; Chen, L; Han, B; Hu, C; Lu, S; Li, W; Song, Y; Wang, J; Zhou, C; Zhou, J; Zhou, Y; Saito, Y; Ichiki, Y; Igai, H; Watanabe, S; Bravaccini, S; Fiorelli, A; Petrella, F; Nakada, T; Solli, P; Tsoukalas, N; Kataoka, Y; Goto, T; Berardi, R; He, J; Zhong, N
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?
2018-01-01 Bravaccini, S; Rocca, A; Bronte, G
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold
2020-01-01 Maltoni, R; Palleschi, M; Ravaioli, S; Tumedei, Mm; Altini, M; Bravaccini, S
Spotlight on PSMA as a new theranostic biomarker for bladder cancer
2021-01-01 Tumedei, Mm; Ravaioli, S; Matteucci, F; Celli, M; De Giorgi, U; Gunelli, R; Puccetti, M; Paganelli, G; Bravaccini, S
The current role of telomerase in the diagnosis of bladder cancer
2009-01-01 Bravaccini, S; Casadio, V; Amadori, D; Calistri, D; Silvestrini, R.
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects
2021-01-01 Bravaccini, S; Bronte, G; Petracci, E; Puccetti, M; D'Arcangelo, M; Ravaioli Tumedei, Mm; Maltoni, R; Delmonte, A; Cappuzzo, F; Crinò, L
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial
2020-01-01 Bravaccini, S; Bronte, G; Scarpi, E; Ravaioli, S; Maltoni, R; Mangia, A; Tumedei, Mm; Puccetti, M; Serra, P; Gianni, L; Amaducci, L; Biglia, N; Bounous, V; Paradiso, Av; Silvestrini, R; Amadori, D; Rocca, A
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer
2021-01-01 Bronte, G; Puccetti, M; Petracci, E; Landi, L; Cravero, P; Scodes, S; Ulivi, P; Ravaioli, S; Tumedei, Mm; Burgio, Ma; Cappuzzo, F; Delmonte, A; Crino, L; Bravaccini, S
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study
2011-01-01 Sacanna, E; Ibrahim, T; Gaudio, M; Mercatali, L; Scarpi, E; Zoli, W; Serra, P; Bravaccini, S; Ricci, R; Serra, L; Amadori, D
TMB in NSCLC: A Broken Dream?
2021-01-01 Bravaccini, S; Bronte, G; Ulivi, P
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients
2014-01-01 Rambau, P; Masalu, N; Jackson, K; Chalya, P; Serra, P; Bravaccini, S
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
2021-01-01 Bravaccini, S; Maltoni, R
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota
2023-01-01 Pirini, F; Cortesi, M; Tumedei, Mm; Zanoni, M; Ravaioli, S; Bravaccini, S
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinomain situ
2020-01-01 Farolfi, A; Petracci, E; Serra, L; Ravaioli, A; Bravaccini, S; Ravaioli, S; Tumedei, Mm; Ulivi, P; Canale, M; Puccetti, M; Falcini, F; Folli, S; Curcio, A; Rocca, A
Urinary biomarkers of nonmuscle-invasive bladder cancer: current status and future potential
2012-01-01 Calistri, D; Casadio, V; Bravaccini, S; Zoli, W; Amadori, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors | 1-gen-2020 | Pasculli, B; Barbano, R; Fontana, A; Biagini, T; Di Viesti, Mp; Rendina, M; Valori, Vm; Morritti, M; Bravaccini, S; Ravaioli, S; Maiello, E; Graziano, P; Murgo, R; Copetti, M; Mazza, T; Fazio, Vm; Esteller, M; Parrella, P | |
| Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer? | 1-gen-2020 | Palleschi, M.; Maltoni, R.; Sarti, S.; Melegari, E.; Bravaccini, S.; Rocca, A. | |
| Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement | 1-gen-2020 | Bronte, G; Delmonte, A; Burgio, Ma; Verlicchi, A; Puccetti, M; Bravaccini, S; Cravero, P; Tumedei, Mm; Diano, D; Rossi, G; Ulivi, P; Martinelli, G; Crino, L | |
| Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer A case report | 1-gen-2020 | Maltoni, R; Palleschi, M; Gallerani, G; Bravaccini, S; Cecconetto, L; Melegari, E; Altini, M; Rocca, A | |
| In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance | 1-gen-2015 | Genestreti, G; Bongiovanni, A; Burgio, Ma; Burgio, Sl; Musto, A; Rossi, A; Monti, M; Scarpi, E; Ulivi, P; Bravaccini, S; Dubini, A; Matteucci, F; Gavelli, G | |
| International consensus on severe lung cancer-the first edition | 1-gen-2021 | Zhou, C; Li, S; Liu, J; Chu, Q; Miao, L; Cai, L; Cai, X; Chen, Y; Cui, F; Dong, Y; Dong, W; Fang, W; He, Y; Li, W; Li, M; Liang, W; Lin, G; Lin, J; Lin, X; Liu, H; Liu, M; Mu, X; Hu, Y; Hu, J; Jin, Y; Li, Z; Qin, Y; Ren, S; Sun, G; Shen, Y; Su, C; Tang, K; Wu, L; Wang, M; Wang, H; Wang, K; Wang, Y; Wang, P; Wang, H; Wang, Q; Wang, Z; Xie, X; Xie, Z; X, Xu; Xu, F; Yang, M; Yang, B; Yi, X; Ye, X; Ye, F; Yu, Z; Yue, D; Zhang, B; Zhang, J; Zhang, J; Zhang, X; Zhang, W; Zhao, W; Zhu, B; Zhu, Z; Zhong, W; Bai, C; Chen, L; Han, B; Hu, C; Lu, S; Li, W; Song, Y; Wang, J; Zhou, C; Zhou, J; Zhou, Y; Saito, Y; Ichiki, Y; Igai, H; Watanabe, S; Bravaccini, S; Fiorelli, A; Petrella, F; Nakada, T; Solli, P; Tsoukalas, N; Kataoka, Y; Goto, T; Berardi, R; He, J; Zhong, N | |
| Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? | 1-gen-2018 | Bravaccini, S; Rocca, A; Bronte, G | |
| Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold | 1-gen-2020 | Maltoni, R; Palleschi, M; Ravaioli, S; Tumedei, Mm; Altini, M; Bravaccini, S | |
| Spotlight on PSMA as a new theranostic biomarker for bladder cancer | 1-gen-2021 | Tumedei, Mm; Ravaioli, S; Matteucci, F; Celli, M; De Giorgi, U; Gunelli, R; Puccetti, M; Paganelli, G; Bravaccini, S | |
| The current role of telomerase in the diagnosis of bladder cancer | 1-gen-2009 | Bravaccini, S; Casadio, V; Amadori, D; Calistri, D; Silvestrini, R. | |
| The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects | 1-gen-2021 | Bravaccini, S; Bronte, G; Petracci, E; Puccetti, M; D'Arcangelo, M; Ravaioli Tumedei, Mm; Maltoni, R; Delmonte, A; Cappuzzo, F; Crinò, L | |
| The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial | 1-gen-2020 | Bravaccini, S; Bronte, G; Scarpi, E; Ravaioli, S; Maltoni, R; Mangia, A; Tumedei, Mm; Puccetti, M; Serra, P; Gianni, L; Amaducci, L; Biglia, N; Bounous, V; Paradiso, Av; Silvestrini, R; Amadori, D; Rocca, A | |
| The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer | 1-gen-2021 | Bronte, G; Puccetti, M; Petracci, E; Landi, L; Cravero, P; Scodes, S; Ulivi, P; Ravaioli, S; Tumedei, Mm; Burgio, Ma; Cappuzzo, F; Delmonte, A; Crino, L; Bravaccini, S | |
| The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study | 1-gen-2011 | Sacanna, E; Ibrahim, T; Gaudio, M; Mercatali, L; Scarpi, E; Zoli, W; Serra, P; Bravaccini, S; Ricci, R; Serra, L; Amadori, D | |
| TMB in NSCLC: A Broken Dream? | 1-gen-2021 | Bravaccini, S; Bronte, G; Ulivi, P | |
| Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients | 1-gen-2014 | Rambau, P; Masalu, N; Jackson, K; Chalya, P; Serra, P; Bravaccini, S | |
| Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls | 1-gen-2021 | Bravaccini, S; Maltoni, R | |
| Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota | 1-gen-2023 | Pirini, F; Cortesi, M; Tumedei, Mm; Zanoni, M; Ravaioli, S; Bravaccini, S | |
| Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinomain situ | 1-gen-2020 | Farolfi, A; Petracci, E; Serra, L; Ravaioli, A; Bravaccini, S; Ravaioli, S; Tumedei, Mm; Ulivi, P; Canale, M; Puccetti, M; Falcini, F; Folli, S; Curcio, A; Rocca, A | |
| Urinary biomarkers of nonmuscle-invasive bladder cancer: current status and future potential | 1-gen-2012 | Calistri, D; Casadio, V; Bravaccini, S; Zoli, W; Amadori, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista16337
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa18
- 2020 - 20277792
- 2010 - 20195948
- 2000 - 20091997
- 1990 - 1999523
- 1980 - 198961
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...240
- JOURNAL OF CLINICAL MEDICINE170
- CANCERS134
- INTERNATIONAL JOURNAL OF ENVIRONM...120
- DIAGNOSTICS88
- LNS. ACTIVITY REPORT85
- SCIENTIFIC REPORTS81
- PHD KORE REVIEW78
- RIVISTA DELLA COOPERAZIONE GIURID...76
- NUTRIENTS75
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19275
- Humans267
- Female142
- Male132
- SARS-CoV-2116
- inflammation110
- oxidative stress88
- Italy86
- Adult73
- Middle Aged72
Lingua
- eng11591
- ita2605
- fre66
- spa66
- ger12
- lat12
- por6
- ara3
- cat3
- enm3
Accesso al fulltext
- no fulltext16340